Junctional adhesion molecule-C is a soluble mediator of angiogenesis

Journal of Immunology

Volumn 185, Issue 3, 2010, Pages 1777-1785

  Rabquer, Bradley J ^a   Amin, Mohammad A ^a   Teegala, Nanditha ^a   Shaheen, Matthew K ^a   Tsou, Pei Suen ^a   Ruth, Jeffrey H ^a   Lesch, Charles A ^a   Imhof, Beat A ^c   Koch, Alisa E ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; ADAM17 PROTEIN; CELL ADHESION MOLECULE; CYTOKINE; JUNCTIONAL ADHESION MOLECULE C; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; AUTACOID; IMMUNOGLOBULIN; JUNCTIONAL ADHESION MOLECULE A , HUMAN; JUNCTIONAL ADHESION MOLECULE-A , HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL IMMORTALIZATION; CELL MIGRATION; CELL SURFACE; CHEMOKINESIS; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOMA; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN SECRETION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SOLUBILITY; SUPERNATANT; SYNOVIAL FLUID; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; CELL LINE; CELL MOTION; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ARTHRITIS, RHEUMATOID; CELL ADHESION MOLECULES; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELLS, CULTURED; HUMANS; IMMUNOGLOBULINS; INFLAMMATION MEDIATORS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; SOLUBILITY; SYNOVIAL FLUID;

EID: 77956419867     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000556     Document Type: Article

References (44)

1. Szekanecz, Z., and A. E. Koch. 2007. Mechanisms of disease: angiogenesis in inflammatory diseases. Nat. Clin. Pract. Rheumatol. 3: 635-643.
2. Szekanecz, Z., L. Gáspár, and A. E. Koch. 2005. Angiogenesis in rheumatoid arthritis. Front. Biosci. 10: 1739-1753.
3. Szekanecz, Z., and A. E. Koch. 1999. Adhesion molecules: potent inducers of endothelial cell chemotaxis. In Tissue Engineering of Vascular Grafts. P. P. Zilla, and H. Greisler, eds. R. G. Landes, Austin, TX, p. 271-277.
4. Volin, M. V. 2005. Soluble adhesion molecules in the pathogenesis of rheumatoid arthritis. Curr. Pharm. Des. 11: 633-653.
5. Pigott, R., L. P. Dillon, I. H. Hemingway, and A. J. Gearing. 1992. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem. Biophys. Res. Commun. 187: 584-589.
6. Koch, A. E., M. M. Halloran, C. J. Haskell, M. R. Shah, and P. J. Polverini. 1995. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376: 517-519.
7. Weber, C., L. Fraemohs, and E. Dejana. 2007. The role of junctional adhesion molecules in vascular inflammation. Nat. Rev. Immunol. 7: 467-477.
8. Martìn-Padura, I., S. Lostaglio, M. Schneemann, L. Williams, M. Romano, P. Fruscella, C. Panzeri, A. Stoppacciaro, L. Ruco, A. Villa, et al. 1998. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142: 117-127. (Pubitemid 28341144)
9. Cunningham, S. A., M. P. Arrate, J. M. Rodriguez, R. J. Bjercke, P. Vanderslice, A. P. Morris, and T. A. Brock. 2000. A novel protein with homology to the junctional adhesion molecule: characterization of leukocyte interactions. J. Biol. Chem. 275: 34750-34756.
10. Palmeri, D., A. van Zante, C. C. Huang, S. Hemmerich, and S. D. Rosen. 2000. Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells. J. Biol. Chem. 275: 19139-19145.
11. Arrate, M. P., J. M. Rodriguez, T. M. Tran, T. A. Brock, and S. A. Cunningham. 2001. Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor. J. Biol. Chem. 276: 45826-45832.
12. Aurrand-Lions, M., L. Duncan, C. Ballestrem, and B. A. Imhof. 2001. JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J. Biol. Chem. 276: 2733-2741.
13. Hirabayashi, S., M. Tajima, I. Yao, W. Nishimura, H. Mori, and Y. Hata. 2003. JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1. Mol. Cell. Biol. 23: 4267-4282.
14. Moog-Lutz, C., F. Cavé-Riant, F. C. Guibal, M. A. Breau, Y. Di Gioia, P. O. Couraud, Y. E. Cayre, S. Bourdoulous, and P. G. Lutz. 2003. JAML, a novel protein with characteristics of a junctional adhesion molecule, is induced during differentiation of myeloid leukemia cells. Blood 102: 3371-3378.
15. Kostrewa, D., M. Brockhaus, A. D'Arcy, G. E. Dale, P. Nelboeck, G. Schmid, F. Mueller, G. Bazzoni, E. Dejana, T. Bartfai, et al. 2001. X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J. 20: 4391-4398. (Pubitemid 32772033)
16. 2 integrin: function in junctional complexes and leukocyte adhesion. Mol. Biol. Cell 16: 4992-5003.
17. Cunningham, S. A., J. M. Rodriguez, M. P. Arrate, T. M. Tran, and T. A. Brock. 2002. JAM2 interacts with a4b1: facilitation by JAM3. J. Biol. Chem. 277: 27589-27592.
18. Ostermann, G., K. S. Weber, A. Zernecke, A. Schröder, and C. Weber. 2002. JAM-1 is a ligand of the b2 integrin LFA-1 involved in transendothelial migration of leukocytes. Nat. Immunol. 3: 151-158.
19. Santoso, S., U. J. Sachs, H. Kroll, M. Linder, A. Ruf, K. T. Preissner, and T. Chavakis. 2002. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J. Exp. Med. 196: 679-691.
20. Zen, K., B. A. Babbin, Y. Liu, J. B. Whelan, A. Nusrat, and C. A. Parkos. 2004. JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration. Mol. Biol. Cell 15: 3926-3937.
21. Rabquer, B. J., A. Pakozdi, J. E. Michel, B. S. Gujar, G. K. Haines, III, B. A. Imhof, and A. E. Koch. 2008. Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium. Arthritis Rheum. 58: 3020-3029.
22. Cooke, V. G., M. U. Naik, and U. P. Naik. 2006. Fibroblast growth factor-2 failed to induce angiogenesis in junctional adhesion molecule-A-deficient mice. Arterioscler. Thromb. Vasc. Biol. 26: 2005-2011.
23. Naik, M. U., S. A. Mousa, C. A. Parkos, and U. P. Naik. 2003. Signaling through JAM-1 and avb3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and avb3 complex. Blood 102: 2108-2114.
24. Naik, M. U., D. Vuppalanchi, and U. P. Naik. 2003. Essential role of junctional adhesion molecule-1 in basic fibroblast growth factor-induced endothelial cell migration. Arterioscler. Thromb. Vasc. Biol. 23: 2165-2171.
25. Lamagna, C., K. M. Hodivala-Dilke, B. A. Imhof, and M. Aurrand-Lions. 2005. Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth. Cancer Res. 65: 5703-5710. (Pubitemid 40911173)
26. Amin, M. A., O. V. Volpert, J. M. Woods, P. Kumar, L. A. Harlow, and A. E. Koch. 2003. Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ. Res. 93: 321-329.
27. Rabquer, B. J., Y. Hou, F. Del Galdo, G. Kenneth Haines, III, M. L. Gerber, S. A. Jimenez, J. R. Seibold, and A. E. Koch. 2009. The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1. Rheumatology (Oxford) 48: 734-740.
28. Ruth, J. H., S. Shahrara, C. C. Park, J. C. Morel, P. Kumar, S. Qin, and A. E. Koch. 2003. Role of macrophage inflammatory protein-3α and its ligand CCR6 in rheumatoid arthritis. Lab. Invest. 83: 579-588.
29. Park, C. C., J. C. Morel, M. A. Amin, M. A. Connors, L. A. Harlow, and A. E. Koch. 2001. Evidence of IL-18 as a novel angiogenic mediator. J. Immunol. 167: 1644-1653.
30. Cavusoglu, E., E. Kornecki, M. B. Sobocka, A. Babinska, Y. H. Ehrlich, V. Chopra, S. Yanamadala, C. Ruwende, M. O. Salifu, L. T. Clark, et al. 2007. Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis. J. Am. Coll. Cardiol. 50: 1768-1776.
31. Salifu, M. O., Q. Kolff, P. Murty, D. M. Haria, M. Zimpa, M. Shakeel, H. Lee, E. Kornecki, and A. Babinska. 2007. Relationship between the soluble F11 receptor and markers of inflammation in hemodialysis patients. J. Investig. Med. 55: 115-119.
32. Gho, Y. S., H. K. Kleinman, and G. Sosne. 1999. Angiogenic activity of human soluble intercellular adhesion molecule-1. Cancer Res. 59: 5128-5132. (Pubitemid 29503972)
33. Koenen, R. R., J. Pruessmeyer, O. Soehnlein, L. Fraemohs, A. Zernecke, N. Schwarz, K. Reiss, A. Sarabi, L. Lindbom, T. M. Hackeng, et al. 2009. Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood 113: 4799-4809.
34. Wellicome, S. M., P. Kapahi, J. C. Mason, Y. Lebranchu, H. Yarwood, and D. O. Haskard. 1993. Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin. Exp. Immunol. 92: 412-418.
35. Robledo, O., A. Papaioannou, B. Ochietti, C. Beauchemin, D. Legault, A. Cantin, P. D. King, C. Daniel, V. Y. Alakhov, E. F. Potworowski, and Y. St- Pierre. 2003. ICAM-1 isoforms: specific activity and sensitivity to cleavage by leukocyte elastase and cathepsin G. Eur. J. Immunol. 33: 1351-1360.
36. Terry, R. W., L. Kwee, J. F. Levine, and M. A. Labow. 1993. Cytokine induction of an alternatively spliced murine vascular cell adhesion molecule (VCAM) mRNA encoding a glycosylphosphatidylinositol-anchored VCAM protein. Proc. Natl. Acad. Sci. USA 90: 5919-5923.
37. Wakatsuki, T., K. Kimura, F. Kimura, N. Shinomiya, M. Ohtsubo, M. Ishizawa, and M. Yamamoto. 1995. A distinct mRNA encoding a soluble form of ICAM-1 molecule expressed in human tissues. Cell Adhes. Commun. 3: 283-292.
38. Staton, C. A., S. M. Stribbling, S. Tazzyman, R. Hughes, N. J. Brown, and C. E. Lewis. 2004. Current methods for assaying angiogenesis in vitro and in vivo. Int. J. Exp. Pathol. 85: 233-248.
39. Kumar, P., M. A. Amin, L. A. Harlow, P. J. Polverini, and A. E. Koch. 2003. Src and phosphatidylinositol 3-kinase mediate soluble E-selectin-induced angiogenesis. Blood 101: 3960-3968.
40. Puxeddu, I., N. Berkman, A. H. Nissim Ben Efraim, D. E. Davies, D. Ribatti, G. J. Gleich, and F. Levi-Schaffer. 2009. The role of eosinophil major basic protein in angiogenesis. Allergy 64: 368-374.
41. Auerbach, R., R. Lewis, B. Shinners, L. Kubai, and N. Akhtar. 2003. Angiogenesis assays: a critical overview. Clin. Chem. 49: 32-40.
42. Norrby, K. 2006. In vivo models of angiogenesis. J. Cell. Mol. Med. 10: 588-612.
43. Eliceiri, B. P., R. Paul, P. L. Schwartzberg, J. D. Hood, J. Leng, and D. A. Cheresh. 1999. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell 4: 915-924.
44. Jiang, B. H., J. Z. Zheng, M. Aoki, and P. K. Vogt. 2000. Phosphatidylinositol 3- kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc. Natl. Acad. Sci. USA 97: 1749-1753.